ArticlePolymers2018
Bimetallic Gold-Silver Nanoparticles Supported on Zeolitic Imidazolate Framework-8 as Highly Active Heterogenous Catalysts for Selective Oxidation of Benzyl Alcohol into Benzaldehyde.
Article in Polymers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 45 citations in OpenAlex.
- Mesoporous Silica-Supported MOF Composites for CONanomaterials (Basel, Switzerland) · 2026Review
- Carboxylate-Ligand-Based Coordination Polymers and Metal Complexes: From Structural Diversity and Supramolecular Descriptors to Function-Oriented Design.Molecules (Basel, Switzerland) · 2026Review
- Cellulose Membranes Embedded with Gold-Silver Bimetallic Nanoparticles for the Efficient Reduction of 4-Nitrophenol.ACS omega · 2025Article
- Bimetallic Au-Ru nanoparticles supported on zeolitic imidazolate framework-67 as highly efficient catalysts for the selective oxidation of benzyl alcohol.Scientific reports · 2025Article
- Efficient oxidation of benzyl alcohol into benzaldehyde catalyzed by graphene oxide and reduced graphene oxide supported bimetallic Au-Sn catalysts.RSC advances · 2023Article
- Multilayered Mesoporous Composite Nanostructures for Highly Sensitive Label-Free Quantification of Cardiac Troponin-I.Biosensors · 2022Article
- Comparative Study of Pd-Ni Bimetallic Catalysts Supported on UiO-66 and UiO-66-NHNanomaterials (Basel, Switzerland) · 2022Article
- Boosting the catalytic behavior and stability of a gold catalyst with structure regulated by ceria.RSC advances · 2022Article
- Bimetallic AgPd/UiO-66 Hybrid Catalysts for Propylene Glycol Oxidation into Lactic Acid.Materials (Basel, Switzerland) · 2020Article
- Bimetallic Au-Pd alloy nanoparticles supported on MIL-101(Cr) as highly efficient catalysts for selective hydrogenation of 1,3-butadiene.RSC advances · 2020Article
- Article
- Supported Gold Nanoparticles as Catalysts for the Oxidation of Alcohols and Alkanes.Frontiers in chemistry · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
The metal-organic zeolite imidazolate framework-8 (ZIF-8) supported gold-silver bimetallic catalysts with a core-shell structure (Au@Ag/ZIF-8 and Ag@Au/ZIF-8) and cluster structure (AuAg/ZIF-8) were successfully prepared by the deposition-redispersion method. Energy dispersive X-ray spectroscopy (EDS) elemental mapping images displayed that in the Au@Ag/ZIF-8 catalyst, Ag atoms were deposited on an exposed Au surface, and core-shell structured Au@Ag particles with highly dispersed Ag as the shell were formed. Additionally, the XPS investigation at gold 4f levels and silver 3d levels indicated that the Au and Ag particles of Au@Ag/ZIF-8, Ag@Au/ZIF-8, and AuAg/ZIF-8 were in a zero valence state. Among the resultant catalysts obtained in this study, Ag@Au/ZIF-8 catalysts showed the highest catalytic activity for the selective oxidation of benzyl alcohol, followed by AuAg/ZIF-8 and Au@Ag/ZIF-8. The turnover frequency (TOF) values were in the order of Ag@Au/ZIF-8 (28.2 h
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.